Ambev S.A.
NYSE:ABEVBeverages - Alcoholic
-$0.02 today
- Market cap
- $42.89B
- Beta
- 0.27
- P/E (TTM)
- 16.2
- EPS (TTM)
- $1.00
- Dividend yield
- 9.76%
Volume 11.24M
Average 27.73M
ABEV Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Ambev S.A.NYSE: ABEV
Free Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Free cash flow growth accelerates
Q2 FY2026 free cash flow of R$3.83B rose 95.3% year over year, ahead of the +10.9% change in trailing-twelve-month free cash flow. Sequentially, it rose 42.2% from the prior quarter. Over 3 fiscal years it compounded at +12.1% a year.
Context
- Free cash flow amounted to 22.5% of revenue in FY2025, down 1.4 pp from a year earlier.
- Free cash flow increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +95.3% holds above the trailing-twelve-month pace of +10.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
BRL · from the cash flow
- Latest · FY2025
- 19.86B BRL
- Year-over-year change
- -7.0%
- 4-year CAGR
- +6.9%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 19.86B | -7.0% |
| FY2024 | 2024-12-31 | 21.35B | +14.1% |
| FY2023 | 2023-12-31 | 18.71B | +32.6% |
| FY2022 | 2022-12-31 | 14.11B | -7.3% |
| FY2021 | 2021-12-31 | 15.22B | — |
Free Cash Flow vs competitors
How ABEV compares with its peers on the latest reported figures
- Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +10.9% is the 2nd highest of 5, against a peer median of +0.2%.
- Free cash flow amounts to 27.2% of revenue for ABEV, versus a peer median of 12.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CLP 130.1B CLP | -16.5% | — | 4.5% | |
| LTM Jun 2026 | R$24.02B BRL | +10.9% | +12.1% | 27.2% | |
| FY2025 | $11.26B USD | +0.8% | +13.2% | 19.0% | |
| LTM Jun 2026 | $3.51B USD | — | -65.8% | 7.3% | |
| LTM Aug 2026 | $1.84B USD | -0.5% | +1.4% | 20.0% | |
| LTM Jun 2026 | $1.33B USD | +38.0% | +8.3% | 12.0% | |
| Peer median (excluding ABEV) | — | +0.2% | +4.8% | 12.0% | |
Competitors are the stored peer set for ABEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 13.12B | 14.89B | 14.96B | 14.85B | 15.99B |
| Depreciation & Amortization | 5.4B | 5.96B | 6.42B | 7.13B | 6.83B |
| Deferred Income Tax | 853.2M | (316M) | 253.8M | 4.91B | 3.7B |
| Stock-Based Compensation | 387.6M | 313.9M | 331.6M | 400.9M | 454.2M |
| Change in Working Capital | 3B | (2.68B) | (296.1M) | (165M) | (1.62B) |
| Accounts Receivables | 341.4M | (322.5M) | (1.37B) | 220.4M | (312.9M) |
| Inventory | (3.5B) | (3.09B) | 1.3B | (1.7B) | (30.9M) |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 6.16B | 726.6M | (223.1M) | 1.32B | (1.27B) |
| Other Non-Cash Items | 141.8M | 2.48B | 3.04B | (1.03B) | (908.2M) |
| Operating Cash Flow | 22.9B | 20.64B | 24.71B | 26.1B | 24.45B |
| Capital Expenditures | (7.68B) | (6.53B) | (6B) | (4.75B) | (4.59B) |
| Acquisitions (Net) | (133.3M) | (33M) | (52.8M) | 10.3M | (91.6M) |
| Purchases of Investments | (241.3M) | (30M) | (6.3M) | (888.6M) | (441.5M) |
| Sales of Investments | 0 | 1.41B | 136.4M | 0 | 0 |
| Other Investing Activities | 316.7M | 178.9M | 160.8M | 164M | 173.5M |
| Investing Cash Flow | (7.74B) | (5B) | (5.77B) | (5.46B) | (4.95B) |
| Debt Repayment | (2.8B) | (810M) | (1.36B) | (1.45B) | (1.28B) |
| Common Stock Issued | 9.1M | 23.8M | 14.5M | 17.5M | 0 |
| Common Stock Repurchased | (44.2M) | (54.1M) | (119M) | (467.6M) | (1.93B) |
| Dividends Paid | (11.12B) | (12.24B) | (11.92B) | (4.06B) | (20.46B) |
| Other Financing Activities | (2.09B) | (3.26B) | (2.73B) | (4.4B) | (3.1B) |
| Financing Cash Flow | (16.04B) | (16.34B) | (16.12B) | (10.35B) | (26.77B) |
| Effect of Forex Changes | 382.6M | (1.05B) | (1.62B) | 2.25B | (2.69B) |
| Net Change in Cash | (493.1M) | (1.75B) | 1.21B | 12.54B | (9.96B) |
| Free Cash Flow | 15.22B | 14.11B | 18.71B | 21.35B | 19.86B |
Ambev S.A.
NYSE:ABEV
Intrinsic Alpha fair value
Locked
Current Price
$2.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.